Emerging Trends 07.27.20
Implementing China’s New Foreign Investment Law
This series of alerts focuses on practical issues relating to China’s new Foreign Investment Law, which came into effect at the beginning of 2020.
Wenjun Cai focuses his practice on mergers and acquisitions, venture capital investments, cross-border investments, competition, international trade, cybersecurity and other general corporate, compliance and regulatory matters.
Wenjun assists multinational and Chinese companies in strategic mergers and acquisitions,private equity transactions and venture capital investments. He also advises more than 60 companies on their operations and compliance in China and overseas in relation to various legal issues, including industry policies, regulatory and compliance requirements, tax, competition, international trade and sanction, cybersecurity protection and employment matters. His clients span across a wide range of industries such as manufacturing, automobile, nuclear, telecommunication, commercial and distribution, aviation, publication, hospitality, etc. Wenjun has considerable expertise in advising non-profit organizations regarding their strategies and operations in China.
Passed the People’s Republic of China (PRC) bar examination in 2016*
*Same as the other international law firms, our China offices and staff are not permitted by the Ministry of Justice of China to practice PRC law.
Representative Experience
- Represented venture capital funds and startup companies in all stages of financing.
- Advised more than 60 international and Chinese companies in their operations in China and elsewhere regarding governance, employment, tax, trade compliance, environmental law, data privacy, intellectual property, competition law, etc.
- Represented leading global alternative asset manager Brookfield Business Partners L.P. on the regulatory and policy aspects of its successful $4.6B acquisition of Westinghouse Electric Company.
View More
- Represented a Chinese company in construction of a cutting experimental nuclear reactor in France and a nuclear power plant in UK.
- Represented Methode Electronics, Inc.’s $480 million acquisition of Grakon, LLC.
- Represented MP Biomedicals LLC, a U.S. biomedical company, in its $142.5 million acquisition by a Chinese investor.
- Represented various clients in relation to U.S. sanction law compliance and delisting from sanction lists.
- Advised more than 30 international NGOs in operating in China, including establishing several of the first China branches established under China’s Foreign NGO Law
- Represented a luxurious automobile company and its China subsidiaries in its day-to-day operations and its innovative projects on automobile after-sale services.
Professional Highlights
- Contributor to Doing Business in China, Juris Publishing Inc., 2016
- Teaching Fellow, Editor of Columbia Journal of Asian Law and Harlan Fiske Stone Scholar at Columbia Law School
Education
-
LL.M., Columbia Law School, 2022
LL.B., University of International Business and Economics, 2016
Admissions
-
People's Republic of China
New York
Languages
-
Chinese (Mandarin)
English